Imatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer. [electronic resource]
Producer: 20080507Description: 211-7 p. digitalISSN:- 1744-8301
- Antineoplastic Agents -- pharmacology
- Autocrine Communication -- drug effects
- Benzamides
- Dermatofibrosarcoma -- drug therapy
- Epidermal Growth Factor -- physiology
- ErbB Receptors -- physiology
- Humans
- Imatinib Mesylate
- Insulin-Like Growth Factor I -- physiology
- Intercellular Signaling Peptides and Proteins -- physiology
- Piperazines -- pharmacology
- Platelet-Derived Growth Factor -- physiology
- Pyrimidines -- pharmacology
- Receptor, IGF Type 1 -- physiology
- Receptors, Growth Factor -- physiology
- Receptors, Vascular Endothelial Growth Factor -- physiology
- Vascular Endothelial Growth Factor A -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.